Latest return on equity
Compass Therapeutics, Inc. - Common Stock Return on equity
Compass Therapeutics, Inc. - Common Stock (CMPX) return on equity with its veri…
Direct answer
Compass Therapeutics, Inc. - Common Stock's return on equity is -45.95%.
The verified market snapshot reports -45.95%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked August 5, 2026.
Verified data
- Return on equity
- -45.95%
Explore related company data
View Compass Therapeutics, Inc. - Common Stock's market capitalizationView Compass Therapeutics, Inc. - Common Stock's price-to-book ratioView Compass Therapeutics, Inc. - Common Stock's dividend yieldView Compass Therapeutics, Inc. - Common Stock's 52-week price rangeView Compass Therapeutics, Inc. - Common Stock's profit marginView Compass Therapeutics, Inc. - Common Stock's debt-to-equity ratioView all Compass Therapeutics, Inc. - Common Stock key metricsReturn to Compass Therapeutics, Inc. - Common Stock profile